0000899243-20-016869.txt : 20200617 0000899243-20-016869.hdr.sgml : 20200617 20200617164626 ACCESSION NUMBER: 0000899243-20-016869 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200615 FILED AS OF DATE: 20200617 DATE AS OF CHANGE: 20200617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Williams Donald Allen CENTRAL INDEX KEY: 0001620013 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38052 FILM NUMBER: 20970260 MAIL ADDRESS: STREET 1: C/O PRYOR CASHMAN LLP STREET 2: 7 TIMES SQUARE CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Forte Biosciences, Inc. CENTRAL INDEX KEY: 0001419041 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261243872 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4242 CAMPUS POINT COURT, SUITE 500 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 412-8400 MAIL ADDRESS: STREET 1: 4242 CAMPUS POINT COURT, SUITE 500 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Tocagen Inc DATE OF NAME CHANGE: 20071120 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2020-06-15 1 0001419041 Forte Biosciences, Inc. FBRX 0001620013 Williams Donald Allen C/O FORTE BIOSCIENCES, INC. 1124 W. CARSON STREET, MRL BLDG. 3-320 TORRANCE CA 90502 1 0 0 0 Exhibit 24 - Power of Attorney /s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact 2020-06-17 EX-24 2 attachment1.htm EX-24 DOCUMENT
                                                                      Exhibit 24

                               POWER OF ATTORNEY

        The undersigned, as a Section 16 reporting person of Forte Biosciences,
Inc. (the "Company"), hereby constitutes and appoints Paul A. Wagner, Antony
Riley, Daniel Koeppen, Benjamin Capps and Thomas Hornish the undersigned's true
and lawful attorneys-in-fact to:

        1.    complete and execute Forms 3, 4 and 5 and other forms and all
              amendments thereto as such attorneys-in-fact shall in their
              discretion determine to be required or advisable pursuant to
              Section 16 of the Securities Exchange Act of 1934 (as amended) and
              the rules and regulations promulgated thereunder, or any successor
              laws and regulations, as a consequence of the undersigned's
              ownership, acquisition or disposition of securities of the
              Company; and

        2.    do all acts necessary in order to file such forms with the
              Securities and Exchange Commission, any securities exchange or
              national association, the Company and such other person or agency
              as the attorneys-in-fact shall deem appropriate.

        The undersigned hereby ratifies and confirms all that said attorneys-in-
fact and agent shall do or cause to be done by virtue hereof.  The undersigned
acknowledges that the foregoing attorneys-in-fact, in serving in such capacity
at the request of the undersigned, is not assuming, nor is the Company assuming,
any of the undersigned's responsibilities to comply with Section 16 of the
Securities Exchange Act of 1934 (as amended).

        This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
Company and the foregoing attorneys-in-fact.

        IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 15th day of June, 2020.


                                        Signature:  /s/ Donald A. Williams
                                                   -----------------------------

                                        Print Name:  Donald A. Williams
                                                   -----------------------------